enlimomab
mAbexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Intercellular adhesion molecule-1ANTAGONIST
ICAM1 antagonist
It attenuates T cell and neutrophil emigration and tissue effector functions by blocking their adhesion to the vascular endothelium through ICAM1.
- Intercellular adhesion molecule-1INHIBITOR
Intercellular adhesion molecule-1 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109090 ↗
- ChEMBLCHEMBL2108401 ↗
Also known as
- birr-1
- enlimomab pegol
- r6.5